Given that androgen signaling does not appear to explain the worse outcomes of men with AML, we explored estrogen receptor (ER) and progesterone receptor (PR) expression on AML cells to test whether estrogen might enhance the effect of chemotherapy. This evidence concerns the gene ESR1 and acute myeloid leukemia.